The Risk Factors for the Wearing-Off Phenomenon in Parkinson's Disease

Introduction: First-line treatment of Parkinson's disease (PD) includes a dopamine analog, levodopa, administered in combination with carbidopa to increase efficacy. Wearing-off (WO) phenomenon is a frequent complication which is defined as a reoccurrence of motor and non-motor symptoms during...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja, Kunal, Ramrakhia, Sonam, Dev, Kapeel, Shahid, Wajeeha, Sohail, Hamza, Memon, Muhammad Khizar, Memon, Sidra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599057/
https://www.ncbi.nlm.nih.gov/pubmed/33145134
http://dx.doi.org/10.7759/cureus.10729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599057/
https://www.ncbi.nlm.nih.gov/pubmed/33145134
http://dx.doi.org/10.7759/cureus.10729

Ejemplares similares